Article
[KIT receptor in testicular seminoma].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie - 1 Feb 2005
Paule Bernard
Abstract excerpt
KIT receptor expression is observed in the majority of seminomas. Activation of KIT tyrosine kinase due to somatic mutations has been demonstrated. Mutations of the c-kit gene in testicular seminomas are located in exon 17. Inhibitors of KIT tyrosine kinase activity can have a therapeutic role, particularly in seminomas with a c-kit mutation sensitive to imatinib mesylate. A clinical trial plans to examine the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
